In this edition of Cardio Conversations, Medtech Insight editor Reed Miller talked to Théophile Mohr Durdez, the CEO and co-founder of Volta Medical, a Marseille-based company applying artificial intelligence to electrophysiology. Volta has raised over €70m and is sponsoring the TAILORED AF trial to show that its software can make atrial fibrillation ablation more effective.
“Success rates for [ablation to treat] paroxysmal atrial fibrillation have been very good. But if you look at the landmark studies of ablation for persistent atrial fibrillation, the success...
